Analysis of Rituximab intensification therapy for low grade B-cell lymphoma refractory to Bendamustine
Not Applicable
- Conditions
- low grade B-cell lymphoma
- Registration Number
- JPRN-UMIN000007110
- Lead Sponsor
- Tokyo women's medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. for whom Bendamustine is contraindication 2. with liver cirrhosis 3. with severe mental disability 4. pregnant or possible to be pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method